Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-intervention (<2 hours)
Awards & highlights
No Placebo-Only Group
Summary
This trial will examine the effects of different cannabis compositions on cardiovascular risks at rest and during exercise.
Eligible Conditions
- Cardiovascular Risk
- Cannabis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, post-intervention (<2 hours)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-intervention (<2 hours)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Aortic Stiffness From Baseline Following Cannabis Consumption
Change in Brachial Artery Vascular Function From Baseline Following Cannabis Consumption
Change in Cardiac Function From Baseline Following Cannabis Consumption
+1 moreSecondary study objectives
Diastolic Blood Pressure
Exercise Capacity
Heart Rate
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Group I: High THC, VaporizedExperimental Treatment1 Intervention
Group II: High THC, SmokedExperimental Treatment1 Intervention
Group III: High CBD, VaporizedExperimental Treatment1 Intervention
Group IV: High CBD, SmokedExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Medical Cannabis
Not yet FDA approved
Find a Location
Who is running the clinical trial?
Jamie BurrLead Sponsor
Share this study with friends
Copy Link
Messenger